SHL Medical is excited to announce its participation in the SCbio 2023 Annual Conference. The event will provide a platform for industry leaders, academic experts, and investors to network, collaborate and learn about the latest trends in biotechnology, healthcare, and life sciences.
In the February issue of ONdrug Delivery magazine, Michael McGowan, Senior Director of Market Intelligence at SHL Medical, examines the emerging interest within the pharmaceutical industry for autoinjectors that are capable of delivering higher injection volumes into the subcutaneous space.
To support the victims of the earthquake in Türkiye and Syria, SHL Medical has donated a total of US$100,000 to the UNHCR and Doctors Without Borders/Médecins Sans Frontières.
SHL Medical is pleased to announce the appointment of Satbir Bains as Chief Human Resources Officer (CHRO) of SHL and a member of the Executive Management Team as of February 2023.
SHL Medical is opening 2023 with our participation in Pharmapack Europe.
SHL Medical is excited to announce our first-time participation in the NSTC Science Train Program, 2022.
In ONdrug Delivery magazine’s October issue on Pre-filled Syringes and Injection Devices, SHL Medical’s Gary Calderwood, Raluca Ganea, and Gene Rhode Fuensalida Pantig talk about the evolving trends in subcutaneous delivery of parenteral formulations, most recently including larger administration volumes.
SHL Medical wins 2022 Excellence Quality Practice Award.
SHL Medical’s FATM and Maggie 5.0 autoinjector are finalists for CPHI Pharma Awards 2022.
Update your browser to view this website correctly. Update my browser now
